Filing Flows › Comparisons › VCYT vs BLLN
Veracyte vs BillionToOne: VCYT and BLLN compared
Veracyte is the larger company: $152M of revenue in its latest quarter (Q3 2026) against $123M for BillionToOne (Q3 2026). BillionToOne is growing faster (+47% against +15% a year earlier). Veracyte is more profitable, with an operating margin of 10.9% against 9.0%.
Where the money goes: VCYT and BLLN
Veracyte (VCYT) · Q3 2026
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
BillionToOne (BLLN) · Q3 2026
BillionToOne, Q3 2026: revenue $123M (+47% year over year), operating margin 9.0%, net earnings $17.4M, operating cash flow $12.5M. The chart follows the revenue to costs, profit and cash.
| Veracyte (VCYT) | BillionToOne (BLLN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $152M | $123M |
| Revenue growth, Y/Y | +15% | +47% |
| Gross margin | 70.6% | 70.9% |
| Operating margin | 10.9% | 9.0% |
| Net earnings | $31.5M | $17.4M |
| Net margin | 20.8% | 14.1% |
| Operating cash flow | $40.3M | $12.5M |
| Free cash flow | $37.9M | $8.6M |
| Market value | $3.7B | — |
| P/E | 32.4× | — |
| Analysts’ mean target | $57.40 | — |
Where the revenue comes from
Veracyte
- Testing revenue: $146M (96%)
- Product revenue: $4.6M (3%)
- Biopharmaceutical and other revenue: $709K (0%)
BillionToOne
- Prenatal: $104M (85%)
- Oncology: $17.1M (14%)
- Clinical trial support and other services: $1.6M (1%)
Questions
Which is bigger, Veracyte or BillionToOne?
Veracyte is the larger company: $152M of revenue in its latest quarter (Q3 2026) against $123M for BillionToOne (Q3 2026).
Is Veracyte or BillionToOne growing faster?
BillionToOne is growing faster (+47% against +15% a year earlier).
Which is more profitable, Veracyte or BillionToOne?
Veracyte is more profitable, with an operating margin of 10.9% against 9.0%.
More: Veracyte earnings · how Veracyte makes money · BillionToOne earnings · how BillionToOne makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.